Luis-Amando García González & Federico Arrutia Díez. (2019). Mucosal bacterial immunotherapy with MV130 highly reduces the need of tonsillectomy in adults with recurrent tonsillitis. Taylor & Francis Group.
Chicago Style (17th ed.) CitationLuis-Amando García González and Federico Arrutia Díez. Mucosal Bacterial Immunotherapy with MV130 Highly Reduces the Need of Tonsillectomy in Adults with Recurrent Tonsillitis. Taylor & Francis Group, 2019.
MLA (9th ed.) CitationLuis-Amando García González and Federico Arrutia Díez. Mucosal Bacterial Immunotherapy with MV130 Highly Reduces the Need of Tonsillectomy in Adults with Recurrent Tonsillitis. Taylor & Francis Group, 2019.
Warning: These citations may not always be 100% accurate.